Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-12-05

FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for Versacloz (clozapine) submitted by TruPharma LLC. This action may involve updates to the product labeling or ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VERSACLOZ (CLOZAPINE)

Snippet

SUPPL AP for VERSACLOZ (CLOZAPINE)